Request for Covid-19 Impact Assessment of this Report
The United States Angiopoietin 2 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Angiopoietin 2 market, reaching US$ million by the year 2028. As for the Europe Angiopoietin 2 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Angiopoietin 2 players cover Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, and Eli Lilly and Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiopoietin 2 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Angiopoietin 2 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Angiopoietin 2 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Angiopoietin 2 by Country/Region, 2017, 2022 & 2028
2.2 Angiopoietin 2 Segment by Type
2.2.1 Atu-111
2.2.2 BI-836880
2.2.3 LY-3127804
2.2.4 MEDI-3617
2.2.5 Others
2.3 Angiopoietin 2 Sales by Type
2.3.1 Global Angiopoietin 2 Sales Market Share by Type (2017-2022)
2.3.2 Global Angiopoietin 2 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Angiopoietin 2 Sale Price by Type (2017-2022)
2.4 Angiopoietin 2 Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Angiopoietin 2 Sales by Application
2.5.1 Global Angiopoietin 2 Sale Market Share by Application (2017-2022)
2.5.2 Global Angiopoietin 2 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Angiopoietin 2 Sale Price by Application (2017-2022)
3 Global Angiopoietin 2 by Company
3.1 Global Angiopoietin 2 Breakdown Data by Company
3.1.1 Global Angiopoietin 2 Annual Sales by Company (2020-2022)
3.1.2 Global Angiopoietin 2 Sales Market Share by Company (2020-2022)
3.2 Global Angiopoietin 2 Annual Revenue by Company (2020-2022)
3.2.1 Global Angiopoietin 2 Revenue by Company (2020-2022)
3.2.2 Global Angiopoietin 2 Revenue Market Share by Company (2020-2022)
3.3 Global Angiopoietin 2 Sale Price by Company
3.4 Key Manufacturers Angiopoietin 2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiopoietin 2 Product Location Distribution
3.4.2 Players Angiopoietin 2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Angiopoietin 2 by Geographic Region
4.1 World Historic Angiopoietin 2 Market Size by Geographic Region (2017-2022)
4.1.1 Global Angiopoietin 2 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Angiopoietin 2 Annual Revenue by Geographic Region
4.2 World Historic Angiopoietin 2 Market Size by Country/Region (2017-2022)
4.2.1 Global Angiopoietin 2 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Angiopoietin 2 Annual Revenue by Country/Region
4.3 Americas Angiopoietin 2 Sales Growth
4.4 APAC Angiopoietin 2 Sales Growth
4.5 Europe Angiopoietin 2 Sales Growth
4.6 Middle East & Africa Angiopoietin 2 Sales Growth
5 Americas
5.1 Americas Angiopoietin 2 Sales by Country
5.1.1 Americas Angiopoietin 2 Sales by Country (2017-2022)
5.1.2 Americas Angiopoietin 2 Revenue by Country (2017-2022)
5.2 Americas Angiopoietin 2 Sales by Type
5.3 Americas Angiopoietin 2 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiopoietin 2 Sales by Region
6.1.1 APAC Angiopoietin 2 Sales by Region (2017-2022)
6.1.2 APAC Angiopoietin 2 Revenue by Region (2017-2022)
6.2 APAC Angiopoietin 2 Sales by Type
6.3 APAC Angiopoietin 2 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Angiopoietin 2 by Country
7.1.1 Europe Angiopoietin 2 Sales by Country (2017-2022)
7.1.2 Europe Angiopoietin 2 Revenue by Country (2017-2022)
7.2 Europe Angiopoietin 2 Sales by Type
7.3 Europe Angiopoietin 2 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Angiopoietin 2 by Country
8.1.1 Middle East & Africa Angiopoietin 2 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Angiopoietin 2 Revenue by Country (2017-2022)
8.2 Middle East & Africa Angiopoietin 2 Sales by Type
8.3 Middle East & Africa Angiopoietin 2 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiopoietin 2
10.3 Manufacturing Process Analysis of Angiopoietin 2
10.4 Industry Chain Structure of Angiopoietin 2
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiopoietin 2 Distributors
11.3 Angiopoietin 2 Customer
12 World Forecast Review for Angiopoietin 2 by Geographic Region
12.1 Global Angiopoietin 2 Market Size Forecast by Region
12.1.1 Global Angiopoietin 2 Forecast by Region (2023-2028)
12.1.2 Global Angiopoietin 2 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiopoietin 2 Forecast by Type
12.7 Global Angiopoietin 2 Forecast by Application
13 Key Players Analysis
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Angiopoietin 2 Product Offered
13.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 AnGes MG, Inc.
13.2.1 AnGes MG, Inc. Company Information
13.2.2 AnGes MG, Inc. Angiopoietin 2 Product Offered
13.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AnGes MG, Inc. Main Business Overview
13.2.5 AnGes MG, Inc. Latest Developments
13.3 Boehringer Ingelheim GmbH
13.3.1 Boehringer Ingelheim GmbH Company Information
13.3.2 Boehringer Ingelheim GmbH Angiopoietin 2 Product Offered
13.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim GmbH Main Business Overview
13.3.5 Boehringer Ingelheim GmbH Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Angiopoietin 2 Product Offered
13.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Information
13.5.2 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Offered
13.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.6 MedImmune, LLC
13.6.1 MedImmune, LLC Company Information
13.6.2 MedImmune, LLC Angiopoietin 2 Product Offered
13.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 MedImmune, LLC Main Business Overview
13.6.5 MedImmune, LLC Latest Developments
13.7 Regeneron Pharmaceuticals, Inc.
13.7.1 Regeneron Pharmaceuticals, Inc. Company Information
13.7.2 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Offered
13.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Regeneron Pharmaceuticals, Inc. Main Business Overview
13.7.5 Regeneron Pharmaceuticals, Inc. Latest Developments
13.8 RXi Pharmaceuticals Corporation
13.8.1 RXi Pharmaceuticals Corporation Company Information
13.8.2 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Offered
13.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 RXi Pharmaceuticals Corporation Main Business Overview
13.8.5 RXi Pharmaceuticals Corporation Latest Developments
13.9 Silence Therapeutics Plc
13.9.1 Silence Therapeutics Plc Company Information
13.9.2 Silence Therapeutics Plc Angiopoietin 2 Product Offered
13.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Silence Therapeutics Plc Main Business Overview
13.9.5 Silence Therapeutics Plc Latest Developments
13.10 Synergys Biotherapeutics, Inc.
13.10.1 Synergys Biotherapeutics, Inc. Company Information
13.10.2 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Offered
13.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Synergys Biotherapeutics, Inc. Main Business Overview
13.10.5 Synergys Biotherapeutics, Inc. Latest Developments
14 Research Findings and Conclusion
Table 1. Angiopoietin 2 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Angiopoietin 2 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Atu-111
Table 4. Major Players of BI-836880
Table 5. Major Players of LY-3127804
Table 6. Major Players of MEDI-3617
Table 7. Major Players of Others
Table 8. Global Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Angiopoietin 2 Sales Market Share by Type (2017-2022)
Table 10. Global Angiopoietin 2 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Angiopoietin 2 Revenue Market Share by Type (2017-2022)
Table 12. Global Angiopoietin 2 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Angiopoietin 2 Sales Market Share by Application (2017-2022)
Table 15. Global Angiopoietin 2 Revenue by Application (2017-2022)
Table 16. Global Angiopoietin 2 Revenue Market Share by Application (2017-2022)
Table 17. Global Angiopoietin 2 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Angiopoietin 2 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Angiopoietin 2 Sales Market Share by Company (2020-2022)
Table 20. Global Angiopoietin 2 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Angiopoietin 2 Revenue Market Share by Company (2020-2022)
Table 22. Global Angiopoietin 2 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Angiopoietin 2 Producing Area Distribution and Sales Area
Table 24. Players Angiopoietin 2 Products Offered
Table 25. Angiopoietin 2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Angiopoietin 2 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Angiopoietin 2 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Angiopoietin 2 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Angiopoietin 2 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Angiopoietin 2 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Angiopoietin 2 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Angiopoietin 2 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Angiopoietin 2 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Angiopoietin 2 Sales Market Share by Country (2017-2022)
Table 38. Americas Angiopoietin 2 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Angiopoietin 2 Revenue Market Share by Country (2017-2022)
Table 40. Americas Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Angiopoietin 2 Sales Market Share by Type (2017-2022)
Table 42. Americas Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Angiopoietin 2 Sales Market Share by Application (2017-2022)
Table 44. APAC Angiopoietin 2 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Angiopoietin 2 Sales Market Share by Region (2017-2022)
Table 46. APAC Angiopoietin 2 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Angiopoietin 2 Revenue Market Share by Region (2017-2022)
Table 48. APAC Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Angiopoietin 2 Sales Market Share by Type (2017-2022)
Table 50. APAC Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Angiopoietin 2 Sales Market Share by Application (2017-2022)
Table 52. Europe Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Angiopoietin 2 Sales Market Share by Country (2017-2022)
Table 54. Europe Angiopoietin 2 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Angiopoietin 2 Revenue Market Share by Country (2017-2022)
Table 56. Europe Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Angiopoietin 2 Sales Market Share by Type (2017-2022)
Table 58. Europe Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Angiopoietin 2 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Angiopoietin 2 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Angiopoietin 2 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Angiopoietin 2 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Angiopoietin 2 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Angiopoietin 2 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Angiopoietin 2
Table 69. Key Market Challenges & Risks of Angiopoietin 2
Table 70. Key Industry Trends of Angiopoietin 2
Table 71. Angiopoietin 2 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Angiopoietin 2 Distributors List
Table 74. Angiopoietin 2 Customer List
Table 75. Global Angiopoietin 2 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Angiopoietin 2 Sales Market Forecast by Region
Table 77. Global Angiopoietin 2 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Angiopoietin 2 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Angiopoietin 2 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Angiopoietin 2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Angiopoietin 2 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Angiopoietin 2 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Angiopoietin 2 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Angiopoietin 2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Angiopoietin 2 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Angiopoietin 2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Angiopoietin 2 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Angiopoietin 2 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Angiopoietin 2 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Angiopoietin 2 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Angiopoietin 2 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Angiopoietin 2 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Angiopoietin 2 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Angiopoietin 2 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Amgen Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Inc. Angiopoietin 2 Product Offered
Table 97. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Amgen Inc. Main Business
Table 99. Amgen Inc. Latest Developments
Table 100. AnGes MG, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 101. AnGes MG, Inc. Angiopoietin 2 Product Offered
Table 102. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. AnGes MG, Inc. Main Business
Table 104. AnGes MG, Inc. Latest Developments
Table 105. Boehringer Ingelheim GmbH Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 106. Boehringer Ingelheim GmbH Angiopoietin 2 Product Offered
Table 107. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Boehringer Ingelheim GmbH Main Business
Table 109. Boehringer Ingelheim GmbH Latest Developments
Table 110. Eli Lilly and Company Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 111. Eli Lilly and Company Angiopoietin 2 Product Offered
Table 112. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Eli Lilly and Company Main Business
Table 114. Eli Lilly and Company Latest Developments
Table 115. F. Hoffmann-La Roche Ltd. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 116. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Offered
Table 117. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. F. Hoffmann-La Roche Ltd. Main Business
Table 119. F. Hoffmann-La Roche Ltd. Latest Developments
Table 120. MedImmune, LLC Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 121. MedImmune, LLC Angiopoietin 2 Product Offered
Table 122. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. MedImmune, LLC Main Business
Table 124. MedImmune, LLC Latest Developments
Table 125. Regeneron Pharmaceuticals, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 126. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Offered
Table 127. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Regeneron Pharmaceuticals, Inc. Main Business
Table 129. Regeneron Pharmaceuticals, Inc. Latest Developments
Table 130. RXi Pharmaceuticals Corporation Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 131. RXi Pharmaceuticals Corporation Angiopoietin 2 Product Offered
Table 132. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. RXi Pharmaceuticals Corporation Main Business
Table 134. RXi Pharmaceuticals Corporation Latest Developments
Table 135. Silence Therapeutics Plc Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 136. Silence Therapeutics Plc Angiopoietin 2 Product Offered
Table 137. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Silence Therapeutics Plc Main Business
Table 139. Silence Therapeutics Plc Latest Developments
Table 140. Synergys Biotherapeutics, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 141. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Offered
Table 142. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Synergys Biotherapeutics, Inc. Main Business
Table 144. Synergys Biotherapeutics, Inc. Latest Developments
List of Figures
Figure 1. Picture of Angiopoietin 2
Figure 2. Angiopoietin 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiopoietin 2 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Angiopoietin 2 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Angiopoietin 2 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Atu-111
Figure 10. Product Picture of BI-836880
Figure 11. Product Picture of LY-3127804
Figure 12. Product Picture of MEDI-3617
Figure 13. Product Picture of Others
Figure 14. Global Angiopoietin 2 Sales Market Share by Type in 2021
Figure 15. Global Angiopoietin 2 Revenue Market Share by Type (2017-2022)
Figure 16. Angiopoietin 2 Consumed in Hospital
Figure 17. Global Angiopoietin 2 Market: Hospital (2017-2022) & (K Pcs)
Figure 18. Angiopoietin 2 Consumed in Clinic
Figure 19. Global Angiopoietin 2 Market: Clinic (2017-2022) & (K Pcs)
Figure 20. Angiopoietin 2 Consumed in Others
Figure 21. Global Angiopoietin 2 Market: Others (2017-2022) & (K Pcs)
Figure 22. Global Angiopoietin 2 Sales Market Share by Application (2017-2022)
Figure 23. Global Angiopoietin 2 Revenue Market Share by Application in 2021
Figure 24. Angiopoietin 2 Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Angiopoietin 2 Revenue Market Share by Company in 2021
Figure 26. Global Angiopoietin 2 Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Angiopoietin 2 Revenue Market Share by Geographic Region in 2021
Figure 28. Global Angiopoietin 2 Sales Market Share by Region (2017-2022)
Figure 29. Global Angiopoietin 2 Revenue Market Share by Country/Region in 2021
Figure 30. Americas Angiopoietin 2 Sales 2017-2022 (K Pcs)
Figure 31. Americas Angiopoietin 2 Revenue 2017-2022 ($ Millions)
Figure 32. APAC Angiopoietin 2 Sales 2017-2022 (K Pcs)
Figure 33. APAC Angiopoietin 2 Revenue 2017-2022 ($ Millions)
Figure 34. Europe Angiopoietin 2 Sales 2017-2022 (K Pcs)
Figure 35. Europe Angiopoietin 2 Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Angiopoietin 2 Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa Angiopoietin 2 Revenue 2017-2022 ($ Millions)
Figure 38. Americas Angiopoietin 2 Sales Market Share by Country in 2021
Figure 39. Americas Angiopoietin 2 Revenue Market Share by Country in 2021
Figure 40. United States Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Angiopoietin 2 Sales Market Share by Region in 2021
Figure 45. APAC Angiopoietin 2 Revenue Market Share by Regions in 2021
Figure 46. China Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Angiopoietin 2 Sales Market Share by Country in 2021
Figure 53. Europe Angiopoietin 2 Revenue Market Share by Country in 2021
Figure 54. Germany Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Angiopoietin 2 Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Angiopoietin 2 Revenue Market Share by Country in 2021
Figure 61. Egypt Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Angiopoietin 2 Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Angiopoietin 2 in 2021
Figure 67. Manufacturing Process Analysis of Angiopoietin 2
Figure 68. Industry Chain Structure of Angiopoietin 2
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...